Skip to content

Article

Albea Group to Carve Out Tubes Segment After A&E Talks Stall; Q1 EBITDA Up 3% YoY to $44M

Sponsor PAI Partners is looking to split its French cosmetics packaging manufacturer Albea Group in two and sell off the larger tubes segment after plans to amend and extend its €646 million term loan B, or TLB, due December 2027 earlier this year have stalled, sources told Octus.

The tubes segment is being marketed at $100 million annualized EBITDA and prospective lenders to the deal signed nondisclosure agreements, or NDAs, in recent weeks, sources said. Feedback from lenders was due last week, the sources added.

Nonbinding offers are due on June 18, one of the sources said.

PAI Partners is working with Barclays to help facilitate the disposal, sources said. Law firm Kirkland & Ellis was hired by the firm for negotiations with lenders during the A&E process, they added.

This latest carve-out comes after Albea Group sold its beauty and personal care service segment, Innovative Beauty Group, or IBG, to Fremman Capital in early 2024, as reported. CVC Credit provided the debt facilities to support the acquisition.

After trading below 90 in late April, Albea Group’s €646 million 2027 term loan, which pays Euribor+500 bps, was quoted at 92.5 today, according to Solve.

Group Financials

Albea Group first-quarter net sales for the three months to March 31 climbed 6% year over year to $326 million, while EBITDA rose 3% to $44 million. The tubes segment accounted for 57% of group net sales, or $186 million, and 59% of EBITDA after the group’s other main segment, cosmetics & fragrances, saw its EBITDA decline by 8% due to operational inefficiencies in the United States and lower export mix in China and Indonesia. Stripping out one-offs, pro forma group revenue and EBITDA accelerated by 7% and 11%, respectively.

Albea’s net leverage ticked upward during the quarter, with post-IFRS leverage rising to 4.3x from 4.1x, primarily driven by expected seasonal cash movements and adverse foreign exchange shifts, according to sources. While total cash burn was $23.3 million, normalized free cash flow turned positive to $16.1 million, a sharp reversal from the negative $3.1 million recorded in the same quarter last year.

The group has a liquidity cushion of $139 million, made up of $44 million in cash and a completely undrawn $95 million RCF due June 2027.

Appetite for the A&E at the beginning of the year soured when the war broke out in Iran due to the company’s exposure to oil, as an input into plastic, as reported.

In the first-quarter results, management reiterated commentary it gave in its fourth-quarter results that the group was well-placed to deal with disruptions caused by the ongoing conflict in the Middle East, according to sources.

However, sources noted that indirect logistics disruptions from the conflict have spilled over into other regions. Specifically, container shortages and transportation bottlenecks tied to the Middle East shipping environment have pressured profitability at Albea’s manufacturing operations in Indonesia.
 

Albea SA
 
03/31/2026
 
EBITDA Multiple
(USD in Millions)
Amount
Maturity
Rate
Book
 
$95M Senior Secured RCF
May-2027
 
 
€646M Term Loan B due 2027 1
749.0
Nov-2027
EURIBOR + 5.000%
 
Recourse Factoring
7.0
 
 
 
Finance Leases
18.0
 
 
 
Other Debt
3.0
 
 
 
C&F Latam Local Debt
38.0
 
 
 
C&F Latam Local Debt
7.0
 
 
 
Total Senior Secured Unsubordinated Debt
822.0
 
4.8x
Total Debt
822.0
 
4.8x
Less: Cash and Equivalents
(44.0)
 
Net Debt
778.0
 
4.5x
Operating Metrics
LTM Reported EBITDA
173.0
 
 
Liquidity
RCF Commitments
95.0
 
Plus: Cash and Equivalents
44.0
 
Total Liquidity
139.0
 
Credit Metrics
Gross Leverage
4.8x
 
Net Leverage
4.5x
 
Notes:
EBITDA is pre IFRS 16 normalised EBITDA.
1. Includes privately placed €90M add-on

PAI Partners declined to comment. Barclays and Kirkland & Ellis did not respond to a request for comment.

This publication has been prepared by Octus Intelligence, Inc. or one of its affiliates (collectively, "Octus") and is being provided to the recipient in connection with a subscription to one or more Octus products. Recipient’s use of the Octus platform is subject to Octus Terms of Use or the user agreement pursuant to which the recipient has access to the platform (the “Applicable Terms”). The recipient of this publication may not redistribute or republish any portion of the information contained herein other than with Octus express written consent or in accordance with the Applicable Terms. The information in this publication is for general informational purposes only and should not be construed as legal, investment, accounting or other professional advice on any subject matter or as a substitute for such advice. The recipient of this publication must comply with all applicable laws, including laws regarding the purchase and sale of securities. Octus obtains information from a wide variety of sources, which it believes to be reliable, but Octus does not make any representation, warranty, or certification as to the materiality or public availability of the information in this publication or that such information is accurate, complete, comprehensive or fit for a particular purpose. Recipients must make their own decisions about investment strategies or securities mentioned in this publication. Octus and its officers, directors, partners and employees expressly disclaim all liability relating to or arising from actions taken or not taken based on any or all of the information contained in this publication. © 2026 Octus. All rights reserved. Octus(TM) and the Octus logo are trademarks of Octus Intelligence, Inc.